Author:
Sielecki Thais M.,Johnson Tricia L.,Liu Jie,Muckelbauer Jodi K.,Grafstrom Robert H.,Cox Sarah,Boylan John,Burton Catherine R.,Chen Haiying,Smallwood Angela,Chang Chong-Hwan,Boisclair Michael,Benfield Pamela A.,Trainor George L.,Seitz Steven P.
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference18 articles.
1. Cyclins and Cyclin-Dependent Kinases: Theme and Variations
2. Cyclin-Dependent Kinase Inhibitors: Useful Targets in Cell Cycle Regulation
3. Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms.
4. Zaharevitz, D.; Kunick, C.; Schultz, C.; Meijer, L.; Leost, M.; Gussio, R.; Senderowicz, A.; Lahusen, T.; Sausville, E. Amer. Assoc. Cancer Res., April 10–14, 1999, Philadelphia, PA.
5. Inhibition of Cyclin-Dependent Kinases by Purine Analogues
Cited by
90 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献